United States · Venture startup
4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$70Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
New Leaf Venture Partners
Yasuda Enteprise Development Co. LtdReported by masshightech.comSEC filing: $13M sold, first sale Mar 2011
No investor was named in the report.
From a historical funding recordSEC filing: $45M sold, first sale Apr 2009
New Leaf Venture Partners
Covera Ventures
Tullis Health InvestorsYasuda Enteprise Development Co. LtdReported by altassets.net
Reported by pehub.comSEC filing: $30M sold, first sale Apr 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Leaf Venture PartnersTullis Health InvestorsYasuda Enteprise Development Co. LtdHunt VenturesCovera VenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Synageva BioPharma's investors include Baker Brothers Investments, New Leaf Venture Partners, Tullis Health Investors, Yasuda Enteprise Development Co. Ltd and Hunt Ventures, and 1 more on record.
Synageva BioPharma has raised $70M across 4 rounds since 2009.
Synageva BioPharma's most recent round was a Venture of $25M in Mar 2011.
Synageva BioPharma's largest round on record is $30M (Series F), in Apr 2009.
Synageva BioPharma's first round on record, in Apr 2009, was backed by Tullis Health Investors and Baker Brothers Investments.
Synageva BioPharma's latest named round is a Venture, in Mar 2011.
Synageva BioPharma is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
